BRCA1 mutation + BRCA2 mutation	Pancreatic Ductal Adenocarcinoma	BRCA1 mutation + BRCA2 mutation	Pancreatic Ductal Adenocarcinoma	Sensitive: C3 – Early Trials Sensitive : C3	Sensitive: C3 – Early Trials Sensitive : C3
BRCA1 mutation + BRCA2 mutation	Breast Cancer	BRCA1 mutation + BRCA2 mutation	Breast Cancer	fluzoparib Sensitive: C3 – Early Trials fluzoparib Sensitive : C3	fluzoparib Sensitive: C3 – Early Trials fluzoparib Sensitive : C3
BRCA1 mutation + BRCA2 mutation	Ovarian Cancer	BRCA1 mutation + BRCA2 mutation	Ovarian Cancer	fluzoparib Sensitive: C3 – Early Trials fluzoparib Sensitive : C3	fluzoparib Sensitive: C3 – Early Trials fluzoparib Sensitive : C3
BRCA1 mutation + BRCA2 mutation	Prostate Cancer	BRCA1 mutation + BRCA2 mutation	Prostate Cancer	GnRH stimulant Resistant: C3 – Early Trials GnRH stimulant Resistant : C3	GnRH stimulant Resistant: C3 – Early Trials GnRH stimulant Resistant : C3

BRCA1 mutation + BRCA2 mutation

Associations